MESA LABORATORIES INC /CO/ (MLAB) stock: key figures, P/E, revenue and dividend
Information Technology · United States · ISIN US59064R1095
MESA LABORATORIES INC /CO/ financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 240.98 m USD | 249.13 m USD |
| Gross profit | 150.87 m USD | 158.27 m USD |
| Operating income | 16.34 m USD | 18.51 m USD |
| EBIT | 17.82 m USD | 22.71 m USD |
| Net income | -1.97 m USD | 6.71 m USD |
| Diluted EPS – continuing operations | -0.36 USD | 1.21 USD |
Full history since 1988, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About MESA LABORATORIES INC /CO/
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
More stocks
- Comintel Corporation Berhad (7195.KL)
- IRONWOOD PHARMACEUTICALS INC (IRWD)
- UNIVERSAL LOGISTICS HOLDINGS, INC. (ULH)
- Hanza AB (HANZA.ST)
- Changzhou Architectural Research Institute Group Co. Ltd. A (301115.SZ)
- Asseco Business Solutions SA (ABS.WA)
- Groupe Crit SA (CEN.PA)
- Zhejiang He Chuan Technology Corp. Ltd. A (688320.SS)
- Zhejiang Dafeng Industrial Co Ltd (603081.SS)
- Develop Global Ltd (DVP.AX)
- Apacer Technology Inc (8271.TW)
- Krispy Kreme, Inc. (DNUT)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.